23 . 09 .2021
Press release
Galderma announces exclusive agreement with Sofregen to develop the next generation of biostimulator fillers using silk-based technology
22 . 09 .2021
Press release
Cetaphil® Announces Major Evolution in Brand’s Mission to Advance Sensitive Skin Science
09 . 09 .2021
Press release
Galderma to present new data from leading aesthetics portfolio and launch RESTYLANE® EYELIGHT™ at AMWC 2021
29 . 06 .2021
Press release
Galderma receives FDA approval for Restylane® Contour for cheek augmentation and correction of midface contour deficiencies
28 . 06 .2021
Press release
Sol-Gel Technologies and Galderma announce exclusive licenses for the commercialization of EPSOLAY® and TWYNEO® in the United States
11 . 06 .2021
Press release
Alluzience®, the first ready-to-use BoNT-A neuromodulator, receives positive decision for use in Europe
19 . 05 .2021
Press release
How Galderma's Environmental, Social and corporate Governance approach guides its roadmap for sustainable growth
11 . 05 .2021
Press release
Galderma launches CETAPHIL® line for sensitive skin and a new DAYLONG® sun protection product in Switzerland